Target intelligence / Profile preview

Pattern recognition receptors for RNA (RNA PRRs)

Target
RNA PRRs
Molecular classification
Receptor, Enzyme, Toll-like receptor, RIG-I-like receptor, RNA helicase
01

Overview

Pattern recognition receptors (PRRs) for RNA are a specialized group of innate immune sensors that detect foreign or misplaced ribonucleic acids to initiate protective immune responses. These receptors are primarily categorized into endosomal Toll-like receptors (TLR3 for dsRNA, TLR7/8 for ssRNA) and cytosolic RIG-I-like receptors (RIG-I and MDA5), which recognize specific molecular patterns such as double-stranded RNA or 5'-triphosphorylated RNA (Kawai & Akira, 2010, Nature Immunology). Upon activation, these sensors trigger signaling cascades involving adapter proteins like TRIF or MAVS, leading to the production of Type I interferons and pro-inflammatory cytokines that inhibit viral replication and prime the adaptive immune system (Chow et al., 2018, Virology). In clinical medicine, RNA PRRs are major therapeutic targets; agonists are developed as vaccine adjuvants and cancer immunotherapies to enhance anti-tumor immunity, while antagonists are explored for treating autoimmune diseases like systemic lupus erythematosus where self-RNA triggers chronic inflammation (Wu & Chen, 2014, Annual Review of Immunology). Understanding the structural basis of RNA recognition and the downstream signaling pathways is critical for developing precise modulators that can distinguish between viral and host RNA to minimize off-target toxicity.

Other names
RNA-sensing pattern recognition receptorsInnate immune RNA sensorsCytosolic RNA sensorsEndosomal RNA sensors
02

Mechanism of action

Agonism of endosomal TLRs (TLR3, TLR7, TLR8) or cytosolic RLRs (RIG-I, MDA5) to induce Type I interferons and pro-inflammatory cytokines; Antagonism to treat autoimmune disorders.

03

Biological functions

Immune responseSignal transductionApoptosisAntiviral defenseCytokine production
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerNeurodegenerative disease
05

Safety considerations

Cytokine stormSystemic inflammationAutoimmunity inductionInjection site reactionsFlu-like symptoms
06

Interacting drugs

Imiquimod

7 more in the full profile.

07

Biomarkers

Interferon-alpha (IFN-α) levelsInterferon-beta (IFN-β) levelsISG15 expressionIP-10 (CXCL10) levelsOAS1 expression

Beyond the preview

Go deeper on Pattern recognition receptors for RNA (RNA PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern recognition receptors for RNA (RNA PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call